SAUNDERS BRENT L
Insider CIK 1268854 · ACT Chairman, President and CEO, Director · SPRY Director · BBIO Director · SKIN Executive Chairman, Director, 10% owner · BLCO Chairman of the Board and CEO, Director · FRX CEO & President, Director · CSCO Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| BLCO Bausch & Lomb Corp | F Tax w/h | 2026-08-05 | 2026-08-07 | 4,231 | $16.76 | $70.9K | 974,158 | SEC↗ |
| BLCO Bausch & Lomb Corp | A Award | 2026-08-05 | 2026-08-07 | 281,879 | — | $0 | 1,256,037 | SEC↗ |
| BLCO Bausch & Lomb Corp | A Award | 2026-08-05 | 2026-08-07 | 281,879 | — | $0 | 1,256,037 | SEC↗ |
| BLCO Bausch & Lomb Corp | F Tax w/h | 2026-08-05 | 2026-08-07 | 4,231 | $16.76 | $70.9K | 974,158 | SEC↗ |
| SPRY ARS Pharmaceuticals, Inc. | A Award deriv | 2026-06-24 | 2026-06-26 | 30,000 | — | $0 | 30,000 | SEC↗ |
| BLCO Bausch & Lomb Corp | F Tax w/h | 2026-05-22 | 2026-05-26 | 2,886 | $15.92 | $45.9K | 978,389 | SEC↗ |
| BLCO Bausch & Lomb Corp | P Buy | 2026-03-06 | 2026-03-10 | 14,700 | $17.14 | $252.0K | 966,575 | SEC↗ |
| BLCO Bausch & Lomb Corp | A Award | 2026-03-06 | 2026-03-10 | 14,700 | — | $0 | 981,275 | SEC↗ |
| BLCO Bausch & Lomb Corp | F Tax w/h | 2026-02-27 | 2026-03-02 | 24,649 | $18.30 | $451.1K | 951,875 | SEC↗ |
| BLCO Bausch & Lomb Corp | F Tax w/h | 2026-02-26 | 2026-03-02 | 22,059 | $18.49 | $407.9K | 976,524 | SEC↗ |
| BLCO Bausch & Lomb Corp | A Award | 2026-02-25 | 2026-02-27 | 327,102 | — | $0 | 998,583 | SEC↗ |
| BLCO Bausch & Lomb Corp | F Tax w/h | 2026-02-23 | 2026-02-25 | 65,444 | $17.99 | $1.18M | 671,481 | SEC↗ |
| BLCO Bausch & Lomb Corp | F Tax w/h | 2025-08-05 | 2025-08-07 | 4,231 | $14.44 | $61.1K | 736,925 | SEC↗ |
| BLCO Bausch & Lomb Corp | A Award deriv | 2025-07-21 | 2025-07-23 | 150,000 | — | $0 | 900,000 | SEC↗ |
| SPRY ARS Pharmaceuticals, Inc. | A Award deriv | 2025-06-25 | 2025-06-27 | 30,000 | — | $0 | 30,000 | SEC↗ |
| SKIN Beauty Health Co | A Award | 2025-06-16 | 2025-06-18 | 73,051 | — | $0 | 5,994,820 | SEC↗ |
| BLCO Bausch & Lomb Corp | A Award | 2025-05-22 | 2025-05-27 | 22,000 | — | $0 | 741,156 | SEC↗ |
| BLCO Bausch & Lomb Corp | P Buy | 2025-05-22 | 2025-05-27 | 22,000 | $11.28 | $248.2K | 719,156 | SEC↗ |
| SPRY ARS Pharmaceuticals, Inc. | M Exercise deriv | 2025-05-20 | 2025-05-22 | 120,000 | — | $0 | 470,950 | SEC↗ |
| SPRY ARS Pharmaceuticals, Inc. | S Sale | 2025-05-20 | 2025-05-22 | 120,000 | $14.25 | $1.71M | 0 | SEC↗ |
| SPRY ARS Pharmaceuticals, Inc. | M Exercise | 2025-05-20 | 2025-05-22 | 120,000 | $1.01 | $121.2K | 120,000 | SEC↗ |
| BLCO Bausch & Lomb Corp | A Award deriv | 2025-02-26 | 2025-02-28 | 600,858 | — | $0 | 600,858 | SEC↗ |
| BLCO Bausch & Lomb Corp | A Award | 2025-02-26 | 2025-02-28 | 168,168 | — | $0 | 697,156 | SEC↗ |
| BLCO Bausch & Lomb Corp | F Tax w/h | 2024-12-23 | 2024-12-26 | 24,649 | $17.83 | $439.5K | 528,988 | SEC↗ |
| BLCO Bausch & Lomb Corp | F Tax w/h | 2024-12-23 | 2024-12-26 | 73,782 | $17.83 | $1.32M | 553,637 | SEC↗ |
| SKIN Beauty Health Co | P Buy | 2024-08-12 | 2024-08-13 | 40,450 | $1.08 | $43.7K | 5,921,769 | SEC↗ |
| BLCO Bausch & Lomb Corp | P Buy | 2024-08-05 | 2024-08-07 | 32,250 | $15.66 | $505.0K | 595,169 | SEC↗ |
| BLCO Bausch & Lomb Corp | A Award | 2024-08-05 | 2024-08-07 | 32,250 | — | $0 | 627,419 | SEC↗ |
| SKIN Beauty Health Co | A Award | 2024-07-08 | 2024-07-10 | 78,534 | — | $0 | 5,881,319 | SEC↗ |
| SPRY ARS Pharmaceuticals, Inc. | A Award deriv | 2024-06-20 | 2024-06-24 | 40,000 | — | $0 | 40,000 | SEC↗ |
| BLCO Bausch & Lomb Corp | A Award deriv | 2024-02-28 | 2024-03-01 | 569,105 | — | $0 | 569,105 | SEC↗ |
| BLCO Bausch & Lomb Corp | A Award | 2024-02-28 | 2024-03-01 | 187,919 | — | $0 | 562,919 | SEC↗ |
| SKIN Beauty Health Co | P Buy | 2023-08-16 | 2023-08-17 | 59,380 | $6.10 | $362.2K | 5,827,453 | SEC↗ |
| SPRY ARS Pharmaceuticals, Inc. | A Award deriv | 2023-06-27 | 2023-06-28 | 40,000 | — | $0 | 40,000 | SEC↗ |
| SKIN Beauty Health Co | A Award | 2023-06-14 | 2023-06-16 | 16,357 | — | $0 | 5,768,073 | SEC↗ |
| SKIN Beauty Health Co | F Tax w/h | 2023-02-03 | 2024-07-10 | 13,548 | $12.90 | $174.8K | 5,802,785 | SEC↗ |
| SKIN Beauty Health Co | F Tax w/h | 2022-12-30 | 2024-07-10 | 2,167 | $9.10 | $19.7K | 5,816,333 | SEC↗ |
| CSCO CISCO SYSTEMS, INC. | A Award | 2022-12-08 | 2022-12-12 | 5,001 | — | $0 | 24,143 | SEC↗ |
| SPRY ARS Pharmaceuticals, Inc. | A Award deriv | 2022-11-08 | 2022-11-10 | 590,950 | — | $0 | 590,950 | SEC↗ |
| SPRY ARS Pharmaceuticals, Inc. | A Award deriv | 2022-11-08 | 2022-11-10 | 153,647 | — | $0 | 153,647 | SEC↗ |
| SKIN Beauty Health Co | F Tax w/h | 2022-09-30 | 2024-07-10 | 2,166 | $11.79 | $25.5K | 5,818,500 | SEC↗ |
| SKIN Beauty Health Co | F Tax w/h | 2022-06-30 | 2024-07-10 | 3,076 | $12.86 | $39.6K | 5,820,666 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | A Award deriv | 2022-06-22 | 2022-06-24 | 104,921 | — | $0 | 104,921 | SEC↗ |
| SKIN Beauty Health Co | F Tax w/h | 2022-03-31 | 2024-07-10 | 3,711 | $16.88 | $62.6K | 5,823,742 | SEC↗ |
| SKIN Beauty Health Co | A Award | 2022-02-04 | 2022-02-08 | 158,450 | — | $0 | 5,751,716 | SEC↗ |
| SKIN Beauty Health Co | A Award | 2022-02-04 | 2022-02-08 | 35,581 | — | $0 | 5,593,266 | SEC↗ |
| SKIN Beauty Health Co | F Tax w/h | 2022-01-27 | 2022-01-31 | 6,812 | $12.24 | $83.4K | 5,557,685 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | P Buy | 2021-12-29 | 2022-01-03 | 17,600 | $14.48 | $254.8K | 17,600 | SEC↗ |
| CSCO | A Award | 2021-12-13 | 2021-12-15 | 4,180 | — | $0 | 32,503 | SEC↗ |
| SKIN Beauty Health Co | A Award deriv | 2021-09-10 | 2021-09-14 | 60,000 | — | $0 | 60,000 | SEC↗ |
| SKIN Beauty Health Co | A Award | 2021-09-10 | 2021-09-14 | 30,963 | — | $0 | 5,564,497 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | A Award deriv | 2021-06-17 | 2021-06-22 | 38,895 | — | $0 | 38,895 | SEC↗ |
| SKIN Beauty Health Co | J Other deriv | 2021-05-14 | 2021-05-18 | 9,333,333 | — | $0 | 0 | SEC↗ |
| SKIN Beauty Health Co | J Other | 2021-05-14 | 2021-05-18 | 11,500,000 | — | $0 | 0 | SEC↗ |
| SKIN Beauty Health Co | A Award deriv | 2021-05-06 | 2021-05-10 | 1,860,000 | — | $0 | 1,860,000 | SEC↗ |
| SKIN Beauty Health Co | M Exercise deriv | 2021-05-04 | 2021-05-10 | 11,500,000 | — | $0 | 0 | SEC↗ |
| SKIN Beauty Health Co | M Exercise | 2021-05-04 | 2021-05-10 | 11,500,000 | — | $0 | 11,500,000 | SEC↗ |
| CSCO CISCO SYSTEMS, INC. | A Award | 2020-12-10 | 2020-12-14 | 5,189 | — | $0 | 27,543 | SEC↗ |
| SKIN Beauty Health Co | A Award deriv | 2020-10-02 | 2021-05-18 | 9,333,333 | — | $0 | 9,333,333 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | A Award deriv | 2020-06-23 | 2020-06-25 | 101,223 | — | $0 | 101,223 | SEC↗ |
| AGN Allergan plc | D To issuer deriv | 2020-05-08 | 2020-05-11 | 3,291 | — | $0 | 0 | SEC↗ |
| AGN Allergan plc | D To issuer deriv | 2020-05-08 | 2020-05-11 | 104,651 | — | $0 | 0 | SEC↗ |
| AGN Allergan plc | D To issuer deriv | 2020-05-08 | 2020-05-11 | 1,018 | — | $0 | 0 | SEC↗ |
| AGN Allergan plc | D To issuer deriv | 2020-05-08 | 2020-05-11 | 9,446 | — | $0 | 0 | SEC↗ |
| AGN Allergan plc | D To issuer deriv | 2020-05-08 | 2020-05-11 | 3,691 | — | $0 | 0 | SEC↗ |
| AGN Allergan plc | D To issuer deriv | 2020-05-08 | 2020-05-11 | 2,790 | — | $0 | 0 | SEC↗ |
| AGN Allergan plc | D To issuer deriv | 2020-05-08 | 2020-05-11 | 83,936 | — | $0 | 0 | SEC↗ |
| AGN Allergan plc | D To issuer deriv | 2020-05-08 | 2020-05-11 | 62,547 | — | $0 | 0 | SEC↗ |
| AGN Allergan plc | D To issuer deriv | 2020-05-08 | 2020-05-11 | 1 | — | $0 | 0 | SEC↗ |
| AGN Allergan plc | D To issuer deriv | 2020-05-08 | 2020-05-11 | 219,667 | — | $0 | 0 | SEC↗ |
| AGN Allergan plc | D To issuer | 2020-05-08 | 2020-05-11 | 149,384 | — | $0 | 0 | SEC↗ |
| AGN Allergan plc | D To issuer | 2020-05-08 | 2020-05-11 | 79,805 | — | $0 | 0 | SEC↗ |
| AGN Allergan plc | A Award | 2020-03-02 | 2020-03-04 | 68,613 | $193.84 | $13.30M | 229,189 | SEC↗ |
| AGN Allergan plc | F Tax w/h | 2019-12-31 | 2020-01-02 | 7,333 | $191.17 | $1.40M | 160,576 | SEC↗ |
| CSCO CISCO SYSTEMS, INC. | A Award | 2019-12-10 | 2019-12-12 | 5,215 | — | $0 | 21,653 | SEC↗ |
| AGN Allergan plc | F Tax w/h | 2019-04-05 | 2019-04-05 | 2,757 | $145.71 | $401.7K | 167,909 | SEC↗ |
| AGN Allergan plc | P Buy | 2019-03-07 | 2019-03-07 | 300 | $142.18 | $42.7K | 169,206 | SEC↗ |
| AGN Allergan plc | P Buy | 2019-03-07 | 2019-03-07 | 860 | $143.70 | $123.6K | 170,066 | SEC↗ |
| AGN Allergan plc | P Buy | 2019-03-07 | 2019-03-07 | 600 | $144.37 | $86.6K | 170,666 | SEC↗ |
| AGN Allergan plc | F Tax w/h | 2018-12-31 | 2019-01-03 | 9,269 | $133.66 | $1.24M | 168,906 | SEC↗ |
| CSCO CISCO SYSTEMS, INC. | A Award | 2018-12-12 | 2018-12-14 | 4,744 | — | $0 | 16,014 | SEC↗ |
| AGN Allergan plc | F Tax w/h | 2018-04-03 | 2018-04-05 | 2,756 | $164.74 | $454.0K | 178,175 | SEC↗ |
| AGN Allergan plc | P Buy | 2018-03-08 | 2018-03-08 | 3,300 | $152.53 | $503.3K | 180,931 | SEC↗ |
| AGN Allergan plc | F Tax w/h | 2017-12-29 | 2018-01-02 | 8,746 | $163.58 | $1.43M | 177,631 | SEC↗ |
| CSCO CISCO SYSTEMS, INC. | A Award | 2017-12-11 | 2017-12-13 | 5,663 | — | $0 | 10,956 | SEC↗ |
| AGN Allergan plc | P Buy | 2017-12-06 | 2017-12-06 | 4,400 | $164.71 | $724.7K | 186,177 | SEC↗ |
| AGN Allergan plc | P Buy | 2017-12-06 | 2017-12-06 | 200 | $165.35 | $33.1K | 186,377 | SEC↗ |
| AGN Allergan plc | M Exercise deriv | 2017-10-26 | 2017-10-30 | 50,599 | — | $0 | 0 | SEC↗ |
| AGN Allergan plc | M Exercise | 2017-10-26 | 2017-10-30 | 50,599 | — | $0 | 181,777 | SEC↗ |
| AGN Allergan plc | P Buy | 2017-06-16 | 2017-09-18 | 44 | $235.96 | $10.3K | 131,178 | SEC↗ |
| AGN Allergan plc | F Tax w/h | 2017-05-15 | 2017-05-16 | 3,450 | $228.22 | $787.4K | 131,092 | SEC↗ |
| AGN Allergan plc | A Award | 2017-04-03 | 2017-04-04 | 27,978 | $237.68 | $6.65M | 134,542 | SEC↗ |
| AGN Allergan plc | P Buy | 2017-03-29 | 2017-09-18 | 43 | $242.21 | $10.3K | 131,135 | SEC↗ |
| CSCO CISCO SYSTEMS, INC. | A Award | 2017-03-13 | 2017-03-14 | 4,728 | — | $0 | 5,168 | SEC↗ |
| AGN Allergan plc | P Buy | 2016-11-21 | 2016-11-21 | 5,250 | $189.13 | $992.9K | 106,564 | SEC↗ |
| AGN Allergan plc | F Tax w/h | 2016-10-01 | 2016-10-03 | 7,587 | $230.31 | $1.75M | 101,314 | SEC↗ |
| AGN Allergan plc | F Tax w/h | 2016-08-15 | 2016-08-17 | 108 | $254.05 | $27.4K | 108,901 | SEC↗ |
| AGN Allergan plc | F Tax w/h | 2016-06-30 | 2016-07-05 | 16,266 | $231.09 | $3.76M | 109,009 | SEC↗ |
| AGN Allergan plc | F Tax w/h | 2015-10-01 | 2015-10-05 | 7,587 | $282.35 | $2.14M | 125,275 | SEC↗ |
| AGN Allergan plc | P Buy | 2015-08-21 | 2015-08-24 | 1,000 | $301.94 | $301.9K | 132,862 | SEC↗ |
| ACT Actavis plc | F Tax w/h | 2015-05-15 | 2015-05-19 | 3,449 | $296.60 | $1.02M | 131,862 | SEC↗ |
| ACT Actavis plc | F Tax w/h | 2014-08-23 | 2014-11-14 | 108 | $226.33 | $24.4K | 96,669 | SEC↗ |
| ACT Actavis plc | F Tax w/h | 2014-08-15 | 2014-11-14 | 88 | $216.10 | $19.0K | 96,777 | SEC↗ |
| ACT Actavis plc | A Award | 2014-07-01 | 2015-03-31 | 135,507 | — | $0 | 135,507 | SEC↗ |
| FRX Forest Laboratories, LLC | D To issuer deriv | 2014-07-01 | 2014-07-02 | 20,000 | — | $0 | 0 | SEC↗ |
| FRX Forest Laboratories, LLC | D To issuer deriv | 2014-07-01 | 2014-07-02 | 7,815 | — | $0 | 0 | SEC↗ |
| FRX Forest Laboratories, LLC | D To issuer deriv | 2014-07-01 | 2014-07-02 | 66,420 | — | $0 | 0 | SEC↗ |
| FRX Forest Laboratories, LLC | D To issuer deriv | 2014-07-01 | 2014-07-02 | 132,432 | — | $0 | 0 | SEC↗ |
| FRX Forest Laboratories, LLC | D To issuer deriv | 2014-07-01 | 2014-07-02 | 2,158 | — | $0 | 0 | SEC↗ |
| FRX Forest Laboratories, LLC | D To issuer deriv | 2014-07-01 | 2014-07-02 | 465,101 | — | $0 | 0 | SEC↗ |
| FRX Forest Laboratories, LLC | D To issuer deriv | 2014-07-01 | 2014-07-02 | 6,969 | — | $0 | 0 | SEC↗ |
| FRX Forest Laboratories, LLC | D To issuer deriv | 2014-07-01 | 2014-07-02 | 5,909 | — | $0 | 0 | SEC↗ |
| ACT Actavis plc | A Award deriv | 2014-07-01 | 2014-07-03 | 222,958 | — | $0 | 222,958 | SEC↗ |
| ACT Actavis plc | A Award deriv | 2014-07-01 | 2014-07-03 | 114,997 | — | $0 | 114,997 | SEC↗ |
| ACT Actavis plc | A Award deriv | 2014-07-01 | 2014-07-03 | 63,566 | — | $0 | 63,566 | SEC↗ |
| ACT Actavis plc | A Award deriv | 2014-07-01 | 2014-07-03 | 104,651 | — | $0 | 104,651 | SEC↗ |
| ACT Actavis plc | A Award deriv | 2014-07-01 | 2014-07-03 | 2,790 | — | $0 | 2,790 | SEC↗ |
| ACT Actavis plc | A Award deriv | 2014-07-01 | 2014-07-03 | 3,691 | — | $0 | 3,691 | SEC↗ |
| ACT Actavis plc | A Award deriv | 2014-07-01 | 2014-07-03 | 9,446 | — | $0 | 9,446 | SEC↗ |
| FRX Forest Laboratories, LLC | D To issuer | 2014-07-01 | 2014-07-02 | 117,699 | — | $0 | 0 | SEC↗ |
| FRX Forest Laboratories, LLC | D To issuer | 2014-07-01 | 2014-07-02 | 137,600 | — | $0 | 0 | SEC↗ |
| ACT Actavis plc | A Award | 2014-07-01 | 2014-07-03 | 96,865 | — | $0 | 96,865 | SEC↗ |
| FRX Forest Laboratories, LLC | A Award deriv | 2014-06-30 | 2014-07-02 | 66,420 | — | $0 | 66,420 | SEC↗ |
| FRX FOREST LABORATORIES INC | A Award deriv | 2014-05-13 | 2014-05-15 | 134,590 | — | $0 | 134,590 | SEC↗ |
| FRX FOREST LABORATORIES INC | A Award | 2014-05-13 | 2014-05-15 | 42,257 | — | $0 | 255,299 | SEC↗ |
| FRX FOREST LABORATORIES INC | A Award deriv | 2013-10-01 | 2013-10-03 | 472,070 | — | $0 | 472,070 | SEC↗ |
| FRX FOREST LABORATORIES INC | A Award | 2013-10-01 | 2013-10-03 | 92,937 | — | $0 | 213,042 | SEC↗ |
| FRX FOREST LABORATORIES INC | A Award | 2013-10-01 | 2013-10-03 | 116,172 | $43.04 | $5.00M | 120,105 | SEC↗ |
| FRX FOREST LABORATORIES INC | A Award deriv | 2013-08-15 | 2013-08-16 | 5,909 | — | $0 | 5,909 | SEC↗ |
| FRX FOREST LABORATORIES INC | A Award | 2013-08-15 | 2013-08-16 | 1,761 | — | $0 | 3,933 | SEC↗ |
| FRX FOREST LABORATORIES INC | A Award deriv | 2012-08-23 | 2012-08-27 | 7,815 | — | $0 | 7,815 | SEC↗ |
| FRX FOREST LABORATORIES INC | A Award | 2012-08-23 | 2012-08-27 | 2,172 | — | $0 | 2,172 | SEC↗ |